OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC.
1:14-cv-04508
Overview
Parties
Counter Claimant
MYLAN LABORATORIES LIMITED NPE (University / Research)
Represented By
6 Attorneys ListedPEPPER HAMILTON , LLP
301 CARNEGIE CENTER, SUITE 400
SAIBER LLC
SAIBER LLC, ONE GATEWAY CENTER
SAIBER LLC
SAIBER LLC, ONE GATEWAY CENTER
CRITCHLEY, KINUM & VAZQUEZ LLC
CRITCHLEY, KINUM & VAZQUEZ LLC, 75 LIVINGSTON AVE.
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 8,759,350 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2017025878 | US Continuation / Sibling | View Official Patent → |
| π―π΅ Japan | JP 2002379003 | Japan Counterpart | View Official Patent → |
| πΊπΈ United States | US 47,048,103 P | US Continuation / Sibling | View Official Patent → |
| π PCT International (WIPO) | WO 2004060374 A1 | PCT World Application | View Official Patent → |
| πΊπΈ United States | US 9,387,182 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8759350
Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
|
Filed: 2003-12-25
Issued: 2014-06-24
|
Active (0.5 yrs remaining)
+1256d PTA
Expires: 2027-06-03
|
|
|
US7853092
Feature block compression/decompression
|
Filed: 2007-01-11
Issued: 2010-12-14
|
Active (2.9 yrs remaining)
+1008d PTA
Expires: 2029-10-15
|
|
|
US8642760
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
|
Filed: 2011-06-23
Issued: 2014-02-04
|
Active (4.6 yrs remaining)
Expires: 2031-06-23
|
|
|
US8017615
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
|
Filed: 2007-04-26
Issued: 2011-09-13
|
Expired (Term Ended)
Expires: 2024-06-16
|
|
|
US8580796
Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
|
Filed: 2012-01-13
Issued: 2013-11-12
|
Active (5.1 yrs remaining)
Expires: 2032-01-13
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
High PTA (+1256 days) / Cellect Scrutiny β Over 1256 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
73
Dispositive
32
Granted
27
Denied
0
Pending / Review
43
Motions by Category
Key Dispositive Motions & Rulings